Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination

Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that...

Descripción completa

Detalles Bibliográficos
Autores principales: Nutalapati, Snigdha, Gupta, Garima, Hildebrandt, Gerhard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572335/
https://www.ncbi.nlm.nih.gov/pubmed/34765210
http://dx.doi.org/10.1002/ccr3.5035
_version_ 1784595193231572992
author Nutalapati, Snigdha
Gupta, Garima
Hildebrandt, Gerhard C.
author_facet Nutalapati, Snigdha
Gupta, Garima
Hildebrandt, Gerhard C.
author_sort Nutalapati, Snigdha
collection PubMed
description Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.
format Online
Article
Text
id pubmed-8572335
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85723352021-11-10 Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination Nutalapati, Snigdha Gupta, Garima Hildebrandt, Gerhard C. Clin Case Rep Case Report Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery. John Wiley and Sons Inc. 2021-11-06 /pmc/articles/PMC8572335/ /pubmed/34765210 http://dx.doi.org/10.1002/ccr3.5035 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Nutalapati, Snigdha
Gupta, Garima
Hildebrandt, Gerhard C.
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_full Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_fullStr Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_full_unstemmed Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_short Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
title_sort rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post covid‐19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572335/
https://www.ncbi.nlm.nih.gov/pubmed/34765210
http://dx.doi.org/10.1002/ccr3.5035
work_keys_str_mv AT nutalapatisnigdha rapidresponsetomycophenolatemofetilincombinationwithromiplostiminacaseofsevererefractoryimmunethrombocytopeniapostcovid19vaccination
AT guptagarima rapidresponsetomycophenolatemofetilincombinationwithromiplostiminacaseofsevererefractoryimmunethrombocytopeniapostcovid19vaccination
AT hildebrandtgerhardc rapidresponsetomycophenolatemofetilincombinationwithromiplostiminacaseofsevererefractoryimmunethrombocytopeniapostcovid19vaccination

Ejemplares similares